Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Cancer Anorexia-Cachexia Syndrome Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Anorexia-Cachexia Syndrome Drugmarket, defines the market attractiveness level of Cancer Anorexia-Cachexia Syndrome Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cancer Anorexia-Cachexia Syndrome Drug industry, describes the types of Cancer Anorexia-Cachexia Syndrome Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Anorexia-Cachexia Syndrome Drug market and the development prospects and opportunities of Cancer Anorexia-Cachexia Syndrome Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Anorexia-Cachexia Syndrome Drug market in Chapter 13.
By Player:
Novartis AG
Aphios Corp
Acacia Pharma Ltd
Obexia AG
Lakewood-Amedex Inc
RaQualia Pharma Inc
Incyte Corp
PsiOxus Therapeutics Ltd
Viking Therapeutics Inc
Aeterna Zentaris Inc
By Type:
NEO-1940
C-1889
DLN-101
Foxo1-nRNA
AVGN-7
Others
By End-User:
Hospital
Clinic
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cancer Anorexia-Cachexia Syndrome Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cancer Anorexia-Cachexia Syndrome Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cancer Anorexia-Cachexia Syndrome Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cancer Anorexia-Cachexia Syndrome Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cancer Anorexia-Cachexia Syndrome Drug Market Analysis and Outlook to 2022
-
7.1 Global Cancer Anorexia-Cachexia Syndrome Drug Consumption (2017-2022)
-
7.2 United States Cancer Anorexia-Cachexia Syndrome Drug Consumption (2017-2022)
-
7.3 Europe Cancer Anorexia-Cachexia Syndrome Drug Consumption (2017-2022)
-
7.4 China Cancer Anorexia-Cachexia Syndrome Drug Consumption (2017-2022)
-
7.5 Japan Cancer Anorexia-Cachexia Syndrome Drug Consumption (2017-2022)
-
7.6 India Cancer Anorexia-Cachexia Syndrome Drug Consumption (2017-2022)
-
7.7 South Korea Cancer Anorexia-Cachexia Syndrome Drug Consumption (2017-2022)
8 Region and Country-wise Cancer Anorexia-Cachexia Syndrome Drug Market Analysis and Outlook to 2028
-
8.1 Global Cancer Anorexia-Cachexia Syndrome Drug Consumption Forecast (2022-2028)
-
8.2 United States Cancer Anorexia-Cachexia Syndrome Drug Consumption Forecast (2022-2028)
-
8.3 Europe Cancer Anorexia-Cachexia Syndrome Drug Consumption Forecast (2022-2028)
-
8.4 China Cancer Anorexia-Cachexia Syndrome Drug Consumption Forecast (2022-2028)
-
8.5 Japan Cancer Anorexia-Cachexia Syndrome Drug Consumption Forecast (2022-2028)
-
8.6 India Cancer Anorexia-Cachexia Syndrome Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Cancer Anorexia-Cachexia Syndrome Drug Consumption Forecast (2022-2028)
9 Global Cancer Anorexia-Cachexia Syndrome Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Cancer Anorexia-Cachexia Syndrome Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global NEO-1940 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global C-1889 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global DLN-101 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Foxo1-nRNA Consumption and Growth Rate (2017-2022)
-
9.1.5 Global AVGN-7 Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Cancer Anorexia-Cachexia Syndrome Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Cancer Anorexia-Cachexia Syndrome Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Cancer Anorexia-Cachexia Syndrome Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global NEO-1940 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global C-1889 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global DLN-101 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Foxo1-nRNA Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global AVGN-7 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cancer Anorexia-Cachexia Syndrome Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Cancer Anorexia-Cachexia Syndrome Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cancer Anorexia-Cachexia Syndrome Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cancer Anorexia-Cachexia Syndrome Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cancer Anorexia-Cachexia Syndrome Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cancer Anorexia-Cachexia Syndrome Drug Market Competitive Analysis
-
14.1 Novartis AG
-
14.1.1 Novartis AG Company Details
-
14.1.2 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Product and Service
-
14.2 Aphios Corp
-
14.2.1 Aphios Corp Company Details
-
14.2.2 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Product and Service
-
14.3 Acacia Pharma Ltd
-
14.3.1 Acacia Pharma Ltd Company Details
-
14.3.2 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Product and Service
-
14.4 Obexia AG
-
14.4.1 Obexia AG Company Details
-
14.4.2 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Product and Service
-
14.5 Lakewood-Amedex Inc
-
14.5.1 Lakewood-Amedex Inc Company Details
-
14.5.2 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Product and Service
-
14.6 RaQualia Pharma Inc
-
14.6.1 RaQualia Pharma Inc Company Details
-
14.6.2 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Product and Service
-
14.7 Incyte Corp
-
14.7.1 Incyte Corp Company Details
-
14.7.2 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Product and Service
-
14.8 PsiOxus Therapeutics Ltd
-
14.8.1 PsiOxus Therapeutics Ltd Company Details
-
14.8.2 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Product and Service
-
14.9 Viking Therapeutics Inc
-
14.9.1 Viking Therapeutics Inc Company Details
-
14.9.2 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Product and Service
-
14.10 Aeterna Zentaris Inc
-
14.10.1 Aeterna Zentaris Inc Company Details
-
14.10.2 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cancer Anorexia-Cachexia Syndrome Drug
-
Figure Cancer Anorexia-Cachexia Syndrome Drug Picture
-
Table Global Cancer Anorexia-Cachexia Syndrome Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Anorexia-Cachexia Syndrome Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Anorexia-Cachexia Syndrome Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cancer Anorexia-Cachexia Syndrome Drug Consumption by Country (2017-2022)
-
Figure United States Cancer Anorexia-Cachexia Syndrome Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Cancer Anorexia-Cachexia Syndrome Drug Consumption and Growth Rate (2017-2022)
-
Figure China Cancer Anorexia-Cachexia Syndrome Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Cancer Anorexia-Cachexia Syndrome Drug Consumption and Growth Rate (2017-2022)
-
Figure India Cancer Anorexia-Cachexia Syndrome Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cancer Anorexia-Cachexia Syndrome Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Anorexia-Cachexia Syndrome Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Cancer Anorexia-Cachexia Syndrome Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cancer Anorexia-Cachexia Syndrome Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cancer Anorexia-Cachexia Syndrome Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cancer Anorexia-Cachexia Syndrome Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cancer Anorexia-Cachexia Syndrome Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cancer Anorexia-Cachexia Syndrome Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NEO-1940 Consumption and Growth Rate (2017-2022)
-
Figure Global C-1889 Consumption and Growth Rate (2017-2022)
-
Figure Global DLN-101 Consumption and Growth Rate (2017-2022)
-
Figure Global Foxo1-nRNA Consumption and Growth Rate (2017-2022)
-
Figure Global AVGN-7 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global NEO-1940 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global C-1889 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global DLN-101 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Foxo1-nRNA Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AVGN-7 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cancer Anorexia-Cachexia Syndrome Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cancer Anorexia-Cachexia Syndrome Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Product and Service
-
Table Aphios Corp (Foundation Year, Company Profile and etc.)
-
Table Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Product and Service
-
Table Acacia Pharma Ltd (Foundation Year, Company Profile and etc.)
-
Table Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Product and Service
-
Table Obexia AG (Foundation Year, Company Profile and etc.)
-
Table Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Product and Service
-
Table Lakewood-Amedex Inc (Foundation Year, Company Profile and etc.)
-
Table Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Product and Service
-
Table RaQualia Pharma Inc (Foundation Year, Company Profile and etc.)
-
Table RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Product and Service
-
Table Incyte Corp (Foundation Year, Company Profile and etc.)
-
Table Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Product and Service
-
Table PsiOxus Therapeutics Ltd (Foundation Year, Company Profile and etc.)
-
Table PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Product and Service
-
Table Viking Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Product and Service
-
Table Aeterna Zentaris Inc (Foundation Year, Company Profile and etc.)
-
Table Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Product and Service
-
